Association of plant-based diet with cardiometabolic multimorbidity trajectory: A prospective study in UK Biobank

Shimin Chen1, Chao Chen1, Li Lin1

  • 1School of Public Health, Guangdong Medical University, Dongguan, 523808 Guangdong, China.

Insights

Plant-based diets, particularly healthy plant-based diets (hPDI), significantly reduce the risk of developing cardiometabolic diseases (CMD) and progressing to cardiometabolic multimorbidity (CMM). Adherence to plant-based eating patterns is linked to lower incidence of FCMD and CMM.

Area of Science:

  • Nutritional Epidemiology
  • Cardiovascular Health
  • Chronic Disease Progression

Background:

  • Plant-based diets are linked to reduced risk of individual cardiometabolic diseases (CMDs).
  • The impact of plant-based diets on the progression to first-occurrence cardiometabolic disease (FCMD), cardiometabolic multimorbidity (CMM), and mortality is not fully understood.

Purpose of the Study:

  • To investigate the association between plant-based dietary patterns and the risk of developing FCMD, CMM, and mortality.
  • To examine how different plant-based diet indices influence disease trajectories.

Main Methods:

  • Analysis of UK Biobank data from 83,610 participants without baseline CMDs.
  • Utilized multi-state models to assess plant-based diet indices (PDI, hPDI, uPDI) and their impact on disease progression over a median follow-up of 15.61 years.

Main Results:

  • Higher adherence to overall PDI and hPDI was associated with a reduced risk of transitioning from health to FCMD and CMM.
  • hPDI showed a particularly strong inverse association with the risk of transitioning to FCMD.
  • Plant-based indices demonstrated differential effects on the transition to diabetes as an FCMD.

Conclusions:

  • High adherence to PDI and hPDI reduces the risk of transitioning from CMD-free status to FCMD, especially for diabetes.
  • Plant-based diets are associated with a lower risk of progressing to CMM.
  • Further research is needed to explore the association of hPDI and uPDI with mortality risk.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...